<table id="id_05a2e25f-a26a-469a-b9c4-efbf26aba1fe" width="692" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_fb2be65b-1ee6-4474-935d-f520c7f55ff6">Table 9. Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablet Dose is 8 to 20% Higher</caption>
<col width="30.2%"></col>
<col width="29.3%"></col>
<col width="14.3%"></col>
<col width="13.4%"></col>
<col width="12.7%"></col>
<tbody>
<tr id="id_d9f747ad-bc02-4a03-a923-2b1a05e51c6b">
<td align="left" rowspan="2" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">
<br/>
<br/>Study Population</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">Regimens</content>
</td>
<td align="left" colspan="3" stylecode="Lrule Botrule" valign="top">
<content stylecode="bold">Relative Bioavailability</content>
</td>
</tr>
<tr id="id_1abbb0e2-8a17-4340-835b-f18e8b88045a">
<td align="left" stylecode="Botrule Rrule" valign="top">Divalproex Sodium Extended-Release Tablets vs. Divalproex Sodium Delayed-Release Tablets</td>
<td align="left" stylecode="Botrule Rrule" valign="top">AUC<sub>24</sub>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">C<sub>max</sub>
</td>
<td align="left" stylecode="Lrule Botrule" valign="top">C<sub>min</sub>
</td>
</tr>
<tr id="id_3ee12959-d5e5-4635-87d9-341efaf820b1">
<td align="left" stylecode="Botrule Rrule" valign="top">Healthy Volunteers (N = 35)</td>
<td align="left" stylecode="Botrule Rrule" valign="top">1000 &amp; 1500 mg Divalproex sodium extended-release tabletsvs. 875 &amp; 1250 mg Divalproex sodium delayed-release tablets</td>
<td align="left" stylecode="Botrule Rrule" valign="top">1.059</td>
<td align="left" stylecode="Botrule Rrule" valign="top">0.882</td>
<td align="left" stylecode="Lrule Botrule" valign="top">1.173</td>
</tr>
<tr id="id_87e514f0-1054-4aa5-a725-f0a1475d9df8">
<td align="left" stylecode="Rrule" valign="top">Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs (N = 64)</td>
<td align="left" stylecode="Rrule" valign="top">1000 to 5000 mg Divalproex sodium extended-release tablets vs. 875 to 4250 mg Divalproex Sodium delayed-release tablets</td>
<td align="left" stylecode="Rrule" valign="top">1.008</td>
<td align="left" stylecode="Rrule" valign="top">0.899</td>
<td align="left" stylecode="Botrule" valign="top">1.022</td>
</tr>
</tbody>
</table>